CN102604138B - Method for preparing chitosan substrate film by self-deposition of micron gel - Google Patents
Method for preparing chitosan substrate film by self-deposition of micron gel Download PDFInfo
- Publication number
- CN102604138B CN102604138B CN 201210063025 CN201210063025A CN102604138B CN 102604138 B CN102604138 B CN 102604138B CN 201210063025 CN201210063025 CN 201210063025 CN 201210063025 A CN201210063025 A CN 201210063025A CN 102604138 B CN102604138 B CN 102604138B
- Authority
- CN
- China
- Prior art keywords
- chitosan
- hydrogel
- micron
- aqueous solution
- mass concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 115
- 238000000034 method Methods 0.000 title claims abstract description 23
- 239000000758 substrate Substances 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 56
- 239000000017 hydrogel Substances 0.000 claims abstract description 46
- 239000000243 solution Substances 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000007864 aqueous solution Substances 0.000 claims abstract description 23
- 239000002253 acid Substances 0.000 claims abstract description 12
- 239000000499 gel Substances 0.000 claims abstract description 11
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 7
- 239000008367 deionised water Substances 0.000 claims abstract description 6
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- 230000001376 precipitating effect Effects 0.000 claims abstract description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 14
- 238000003381 deacetylation reaction Methods 0.000 claims description 10
- 239000011159 matrix material Substances 0.000 claims description 10
- 230000006196 deacetylation Effects 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 5
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004100 Oxytetracycline Substances 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims description 2
- 229960000625 oxytetracycline Drugs 0.000 claims description 2
- 235000019366 oxytetracycline Nutrition 0.000 claims description 2
- YLLIGHVCTUPGEH-UHFFFAOYSA-M potassium;ethanol;hydroxide Chemical compound [OH-].[K+].CCO YLLIGHVCTUPGEH-UHFFFAOYSA-M 0.000 claims description 2
- OVYTZAASVAZITK-UHFFFAOYSA-M sodium;ethanol;hydroxide Chemical compound [OH-].[Na+].CCO OVYTZAASVAZITK-UHFFFAOYSA-M 0.000 claims description 2
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 claims description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 2
- 229960000401 tranexamic acid Drugs 0.000 claims description 2
- 230000023555 blood coagulation Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 230000002439 hemostatic effect Effects 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 230000035699 permeability Effects 0.000 abstract description 3
- 238000001035 drying Methods 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 2
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 230000010355 oscillation Effects 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 description 13
- 230000007935 neutral effect Effects 0.000 description 7
- 229920002101 Chitin Polymers 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000002585 base Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 208000023329 Gun shot wound Diseases 0.000 description 1
- -1 N-acetyl-2-acetylamino-D-glucose Chemical compound 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000000402 conductometric titration Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- FZAQMSARZVYAAV-UHFFFAOYSA-N propane-1,2,3-triol silver Chemical compound [Ag].OCC(O)CO FZAQMSARZVYAAV-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
技术领域 technical field
本发明涉及一种壳聚糖基体膜的制备方法,尤其是微米凝胶自沉积制备壳聚糖基体膜的方法。 The invention relates to a preparation method of a chitosan matrix film, in particular to a method for preparing a chitosan matrix film by micro-gel self-deposition.
背景技术 Background technique
壳聚糖(Chitosan),学名(1,4)-2-氨基-2-脱氧-β-D-葡萄糖,是由甲壳素(N-乙酰-2-乙酰氨基-D-葡萄糖以1-4糖苷键连接而成)经脱乙酰化反应后得到的一种生物高分子,其分子链中通常含有N-乙酰胺基葡萄糖和N-氨基葡萄糖两种结构单元,两者的比例随脱乙酰化程度的不同而不同。 Chitosan (Chitosan), scientific name (1,4)-2-amino-2-deoxy-β-D-glucose, is composed of chitin (N-acetyl-2-acetylamino-D-glucose with 1-4 glycoside bonded) a biopolymer obtained after deacetylation reaction, its molecular chain usually contains two structural units of N-acetylglucose and N-glucosamine, the ratio of which varies with the degree of deacetylation different from each other.
甲壳素(chitin)来源于海洋贝壳类及藻类,壳聚糖是甲壳素的脱乙酰产物。壳聚糖一种天然弱碱性生物质糖,具有优异的生物相容性,无毒,具有抗菌、止血、促进伤口愈合的功能。目前壳聚糖的应用日渐广泛,包括医用、农业、化妆品等领域。其中在医用领域的应用近年来日益引起人们的关注。例如美国Hemcon公司的壳聚糖止血绷带(Chitosan Bandages),主要用于急性外伤出血及枪伤的现场止血治疗,已作为美军士兵人手必备的急救用品;英国的“CELOX”止血粉(2006年通过美国的FDA认证及欧盟的CE认证;2010年通过中国食品药品监督管理局认证)。 Chitin is derived from marine shellfish and algae, and chitosan is the deacetylation product of chitin. Chitosan is a natural weakly alkaline biomass sugar with excellent biocompatibility, non-toxic, antibacterial, hemostatic, and wound healing functions . At present, chitosan is widely used, including medical, agricultural, cosmetic and other fields. Among them, the application in the medical field has attracted people's attention in recent years. For example, the chitosan hemostatic bandage (Chitosan Bandages) of Hemcon Company in the United States is mainly used for on-site hemostatic treatment of acute traumatic bleeding and gunshot wounds. Passed the FDA certification of the United States and the CE certification of the European Union; in 2010, it was certified by the China Food and Drug Administration).
壳聚糖结构紧密,具有较高的结晶度,无熔点,难以用常规方法如熔融注塑等方法制备成型。突破壳聚糖加工成型难题是扩大壳聚糖应用领域的有效途径。目前壳聚糖的成型方式包括静电电纺丝、溶液拉伸纺丝,壳聚糖膜的制备目前主要采用溶液浇注法,即将壳聚糖预先溶解于酸或者碱溶剂中,浇注入模具后干燥成型。主要有下面几种:方法一,溶液注入模具后直接干燥成膜;方法二,溶液注入模具后干燥成膜,然后用碱或者酸中和,水洗至中性后再干燥成膜;方法三,溶液注入模具,用碱液或者酸液逐步中和得到板状凝胶,水洗至中性后再干燥成膜。方法一得到的是含有酸或者碱的膜,不利于长期保存;后两种方法得到的是中性的膜。这三种方法最后获得的都是致密膜,当吸水时都会膨胀卷曲,不利于应用。方法二制备过程中即很容易引起膜的卷曲。方法三类似于原位沉析法,在逐步中和的过程中,壳聚糖凝胶会形成分层,干燥过程中凝胶会发生变形甚至卷曲。因此,壳聚糖膜的制备工艺还有待改进。 Chitosan has a compact structure, high crystallinity, no melting point, and it is difficult to be prepared by conventional methods such as melt injection molding. It is an effective way to expand the application field of chitosan to break through the problem of chitosan processing and molding. At present, chitosan molding methods include electrospinning, solution stretching and spinning, and the preparation of chitosan film is currently mainly using the solution casting method, that is, chitosan is pre-dissolved in acid or alkali solvent, poured into the mold and then dried. forming. There are mainly the following types: Method 1, the solution is injected into the mold and dried directly to form a film; Method 2, the solution is injected into the mold and dried to form a film, then neutralized with alkali or acid, washed with water until neutral, and then dried to form a film; Method 3, The solution is injected into the mold, gradually neutralized with lye or acid solution to obtain a plate-shaped gel, washed with water until neutral, and then dried to form a film. The first method obtains a film containing acid or alkali, which is not conducive to long-term storage; the latter two methods obtain a neutral film. The final result of these three methods is a dense film, which will swell and curl when absorbing water, which is not conducive to application. The curling of the film is easily caused during the preparation process of the second method. Method 3 is similar to the in-situ precipitation method. During the gradual neutralization process, the chitosan gel will form layers, and the gel will deform or even curl during the drying process. Therefore, the preparation technology of chitosan film still needs to be improved.
发明内容 Contents of the invention
本发明的目的是提供一种制备工艺简单的微米凝胶自沉积制备壳聚糖基体膜的方法,以获得疏松且遇水不卷曲的膜。 The purpose of the present invention is to provide a method for preparing a chitosan matrix film by self-deposition of micro-gel with simple preparation process, so as to obtain a film that is loose and does not curl when exposed to water.
为达到上述目的,本发明的微米凝胶自沉积制备壳聚糖基体膜的方法,包括以下步骤: In order to achieve the above object, the method for preparing the chitosan matrix film from microgel self-deposition of the present invention may further comprise the steps:
第一步: first step:
将壳聚糖溶解于稀酸水溶液中,配制成质量浓度2%的壳聚糖酸溶液,过滤除去不溶物质,超声振荡,同时向溶液中逐滴加入壳聚糖沉析剂,析出壳聚糖凝胶,超声振荡控制壳聚糖凝胶粒径在100~500μm之间,制得壳聚糖微米水凝胶悬浮液; Dissolve chitosan in dilute acid aqueous solution to prepare a chitosan acid solution with a mass concentration of 2%, filter to remove insoluble matter, and ultrasonically oscillate, while adding chitosan precipitant drop by drop to the solution to precipitate chitosan Gel, ultrasonic vibration control chitosan gel particle size between 100 ~ 500 μm, prepared chitosan micron hydrogel suspension;
第二步: Step two:
将第一步制得的壳聚糖微米水凝胶悬浮液用去离子水洗涤至pH值为7.4,过滤,得到壳聚糖微米水凝胶; The chitosan micron hydrogel suspension prepared in the first step is washed with deionized water to a pH value of 7.4, and filtered to obtain chitosan micron hydrogel;
第三步: third step:
将第二步制得的壳聚糖微米水凝胶浸入质量浓度为0.5%~10%的丙三醇水溶液中30—60min后,过滤,得到丙三醇增塑的壳聚糖微米水凝胶; Immerse the chitosan micron hydrogel prepared in the second step in a glycerol aqueous solution with a mass concentration of 0.5% to 10% for 30-60 minutes, and then filter to obtain a glycerin-plasticized chitosan micron hydrogel ;
第四步: the fourth step:
将丙三醇增塑的壳聚糖微米水凝胶离心,控制丙三醇增塑的壳聚糖微米水凝胶含水率为壳聚糖质量的100%~500%;然后将丙三醇增塑的壳聚糖微米水凝胶注入模具中,在真空或者常压条件下于45~80℃烘干,得到壳聚糖基体膜。 The chitosan micro-hydrogel plasticized by glycerol is centrifuged, and the water content of the chitosan micro-hydrogel plasticized by glycerol is controlled to be 100% to 500% of the chitosan quality; The molded chitosan micron hydrogel is injected into a mould, and dried at 45-80° C. under vacuum or normal pressure conditions to obtain a chitosan matrix film.
本发明中,所述壳聚糖的脱乙酰度为50%~100%,分子量为100000~500000。脱乙酰度的计算方式如:《分析化学研究简报》2002年第7期第846~848页,贾之慎、李秀玲所撰写的《酸碱电导滴定法测定壳聚糖脱乙酰度》。 In the present invention, the degree of deacetylation of the chitosan is 50%-100%, and the molecular weight is 100000-500000. The calculation method of the degree of deacetylation is as follows: "Determination of the degree of deacetylation of chitosan by acid-base conductometric titration" written by Jia Zhishen and Li Xiuling in "Analytical Chemistry Research Bulletin" No. 7, 2002, pages 846-848.
为了赋予壳聚糖基体膜具有止血或者抗菌的功能,可以在丙三醇水溶液中加入三七素、CaCl2或氨甲环酸凝血药物,或者加入土霉素或纳米银抗菌活性物质。药物的加入量根据需要选择。 In order to endow the chitosan base film with hemostatic or antibacterial function, three seven elements, CaCl 2 or tranexamic acid coagulation drugs can be added to the glycerol aqueous solution, or oxytetracycline or nano silver antibacterial active substances can be added. The addition amount of medicine is selected according to need.
本发明中,所用的模具可以是培养皿等类似具有敞口,其它部位密封的器皿;也可以是分样筛等类似具有敞口,底部具有多孔纱网的器具。 Among the present invention, used mold can be the vessel such as petri dish etc. that has opening, and other positions are sealed; It can also be the similar opening such as sample sieve, the utensil that has porous gauze at the bottom.
本发明中,所述的稀酸是质量浓度为1%~5%的甲酸水溶液、质量浓度为1%~5%的乙酸水溶液或者质量浓度为1%~5%的盐酸水溶液。 In the present invention, the dilute acid is an aqueous formic acid solution with a mass concentration of 1% to 5%, an aqueous acetic acid solution with a mass concentration of 1% to 5%, or an aqueous hydrochloric acid solution with a mass concentration of 1% to 5%.
本发明中,所述的壳聚糖沉析剂可以是质量浓度为5%的NaOH水溶液、质量浓度为5%的KOH水溶液、质量浓度为5%的NaOH乙醇溶液或者是质量浓度为5%的KOH乙醇溶液。 In the present invention, described chitosan precipitating agent can be the NaOH aqueous solution that mass concentration is 5%, the KOH aqueous solution that mass concentration is 5%, the NaOH ethanol solution that mass concentration is 5% or that mass concentration is 5% KOH ethanol solution.
本发明具有下列优点和效果: The present invention has following advantage and effect:
1、本发明利用壳聚糖微米水凝胶颗粒之间的毛细作用力及范德华力相互连接,干燥成型,不需要加入交联剂,只需一次洗涤,大大简化了制备工艺,可快速制备出平整、规则的壳聚糖膜。 1. The present invention utilizes the capillary force and van der Waals force between chitosan micron hydrogel particles to connect each other, dry and shape, no need to add cross-linking agent, only need to wash once, which greatly simplifies the preparation process, and can be quickly prepared Flat, regular chitosan film.
2、本发明制备的壳聚糖膜,结构疏松,具有高的水通透性,遇水不卷曲,顺从性高,可方便的贴附于各种表面。 2. The chitosan film prepared by the present invention has a loose structure, high water permeability, does not curl when exposed to water, has high compliance, and can be easily attached to various surfaces.
3、本发明使用中性的壳聚糖微米水凝胶,可方便在壳聚糖中加载各种止血或者抗菌的药物活性成分,是一种良好的药物载体。 3. The present invention uses neutral chitosan micron hydrogel, which can conveniently load various hemostatic or antibacterial drug active ingredients in chitosan, and is a good drug carrier.
具体实施方式 Detailed ways
下面结合实施例对本发明作进一步描述: The present invention will be further described below in conjunction with embodiment:
实施例1: Example 1:
(1)取2g脱乙酰度95%,分子量100,000的壳聚糖,加入200ml质量浓度为 2%乙酸水溶液,室温搅拌至完全溶解,配制成1%(m/v)的壳聚糖乙酸水溶液,静置脱泡;将上述溶液过滤,在超声分散器中超声振荡,同时在溶液中逐滴加入5%氢氧化钠水溶液,直至完全沉淀,制得壳聚糖微米水凝胶悬浮液,所得的壳聚糖微米凝胶的粒径在300~500μm之间; (1) Take 2g of chitosan with a deacetylation degree of 95% and a molecular weight of 100,000, add 200ml of 2% acetic acid aqueous solution, stir at room temperature until completely dissolved, and prepare a 1% (m/v) chitosan acetic acid aqueous solution. Stand still for defoaming; filter the above solution, ultrasonically vibrate in an ultrasonic disperser, and simultaneously add 5% aqueous sodium hydroxide solution dropwise to the solution until it completely precipitates to obtain a chitosan micron hydrogel suspension. The particle size of chitosan microgel is between 300 and 500 μm;
(2)用去离子水冲洗壳聚糖微米水凝胶悬浮液至中性pH=7.4,过滤,得到壳聚糖微米水凝胶; (2) Rinse the chitosan micron hydrogel suspension with deionized water to neutral pH=7.4, filter to obtain chitosan micron hydrogel;
(3)将制得的壳聚糖微米水凝胶浸入质量浓度1%的丙三醇溶液中,30min后,过滤,得到丙三醇增塑的壳聚糖微米水凝胶; (3) Immerse the prepared chitosan micron hydrogel in a glycerol solution with a mass concentration of 1%, and filter after 30 minutes to obtain a chitosan micron hydrogel plasticized with glycerol;
(4)将丙三醇增塑的壳聚糖微米水凝胶进行离心,去除多余的水,控制丙三醇增塑的壳聚糖微米水凝胶含水率为壳聚糖质量的100%,然后将丙三醇增塑的壳聚糖微米水凝胶注入模具中,常压条件下于60℃烘干,得到壳聚糖基体膜。该壳聚糖膜具有高的水通透性,遇水不卷曲。 (4) Centrifuge the chitosan micro-hydrogel plasticized with glycerol to remove excess water, and control the moisture content of the chitosan micro-hydrogel plasticized with glycerol to be 100% of the chitosan quality, Then inject the chitosan micron hydrogel plasticized by glycerol into the mould, and dry at 60° C. under normal pressure to obtain the chitosan matrix film. The chitosan film has high water permeability and does not curl when exposed to water.
实施例2: Example 2:
(1)取2g脱乙酰度85%,分子量200,000的壳聚糖,加入200ml质量浓度为 2%盐酸水溶液,室温搅拌至完全溶解,配制成1%(m/v)的壳聚糖盐酸水溶液,静置脱泡;将上述溶液过滤,在超声分散器中超声振荡,同时在溶液中逐滴加入5%氢氧化钾水溶液,直至完全沉淀,制得壳聚糖微米水凝胶悬浮液,所得的壳聚糖微米凝胶的粒径在100~300μm之间; (1) Take 2g of chitosan with a deacetylation degree of 85% and a molecular weight of 200,000, add 200ml of a 2% hydrochloric acid aqueous solution, stir at room temperature until completely dissolved, and prepare a 1% (m/v) chitosan hydrochloric acid aqueous solution, Stand still for defoaming; filter the above solution, ultrasonically vibrate in an ultrasonic disperser, and simultaneously add 5% potassium hydroxide aqueous solution dropwise to the solution until it completely precipitates to obtain a micron hydrogel suspension of chitosan. The particle size of chitosan microgel is between 100 and 300 μm;
(2)用去离子水冲洗壳聚糖微米水凝胶至中性pH=7.4,过滤,得到壳聚糖微米水凝胶; (2) Rinse chitosan micron hydrogel with deionized water to neutral pH=7.4, filter to obtain chitosan micron hydrogel;
(3)将制得的壳聚糖微米水凝胶浸入含有质量浓度1%丙三醇、0.5%CaCl2和1%三七素溶液中,30min后过滤,得到含CaCl2和三七素的丙三醇增塑壳聚糖微米水凝胶; (3) Immerse the prepared chitosan micron hydrogel in a solution containing 1% glycerol, 0.5% CaCl and 1% notoginseng, and filter after 30 minutes to obtain CaCl and notoginsin Glycerol plasticized chitosan micron hydrogel;
(4)将第(3)步的含CaCl2和三七素的丙三醇增塑壳聚糖微米水凝胶进行离心,去除多余的水,控制壳聚糖微米水凝胶含水率为壳聚糖质量的100%,然后将含CaCl2和三七素的丙三醇增塑壳聚糖微米水凝胶注入模具中,在真空条件下于45℃烘干,得到含有CaCl2和三七素的丙三醇增塑的壳聚糖膜,这种膜可用于快速止血。 (4) Centrifuge the glycerol-plasticized chitosan micron hydrogel containing CaCl2 and notoginsin in step (3) to remove excess water, and control the water content of the chitosan micron hydrogel to the shell 100% polysaccharide quality, then inject the glycerol plasticized chitosan micron hydrogel containing CaCl 2 and notoginseng into the mold, and dry it at 45°C under vacuum to obtain CaCl 2 and notoginseng Glycerin-plasticized chitosan film, which can be used for rapid hemostasis.
实施例3: Example 3:
(1)取2g脱乙酰度75%,分子量500,000的壳聚糖,加入200ml质量浓度为 2%乙酸水溶液,室温搅拌至完全溶解,配制成1%(m/v)的壳聚糖乙酸水溶液,静置脱泡;将上述溶液过滤,在超声分散器中超声振荡,同时在溶液中逐滴加入5%氢氧化钠水溶液,直至完全沉淀,制得壳聚糖微米水凝胶悬浮液,所得的壳聚糖微米凝胶的粒径在100~300μm之间; (1) Take 2g of chitosan with a deacetylation degree of 75% and a molecular weight of 500,000, add 200ml of 2% acetic acid aqueous solution, stir at room temperature until completely dissolved, and prepare a 1% (m/v) chitosan acetic acid aqueous solution. Stand still for defoaming; filter the above solution, ultrasonically vibrate in an ultrasonic disperser, and simultaneously add 5% aqueous sodium hydroxide solution dropwise to the solution until it completely precipitates to obtain a chitosan micron hydrogel suspension. The particle size of chitosan microgel is between 100 and 300 μm;
(2)用去离子水冲洗壳聚糖微米水凝胶至中性pH=7.4,过滤,得到壳聚糖微米水凝胶; (2) Rinse chitosan micron hydrogel with deionized water to neutral pH=7.4, filter to obtain chitosan micron hydrogel;
(3)将制得的壳聚糖微米水凝胶浸入含有质量浓度1%丙三醇、1%三七素和0.5%纳米银的水溶液中,30min后,过滤,得到含有三七素和纳米银的丙三醇增塑的壳聚糖微米水凝胶; (3) Immerse the prepared chitosan micron hydrogel in an aqueous solution containing mass concentrations of 1% glycerin, 1% notoginsin and 0.5% nano-silver. After 30 minutes, filter to obtain Silver glycerol plasticized chitosan micron hydrogel;
(4)将含有三七素和纳米银的丙三醇增塑的壳聚糖微米水凝胶进行离心,去除多余的水,控制壳聚糖微米水凝胶含水率为壳聚糖质量的200%,然后将含有三七素和纳米银的丙三醇增塑的壳聚糖微米水凝胶注入模具中,在真空条件下于80℃烘干,得到含有三七素和纳米银的壳聚糖膜。这种壳聚糖膜具有抗菌止血的功能。 (4) Centrifuge the glycerin-plasticized chitosan micron hydrogel containing notoginseng and nano-silver to remove excess water, and control the water content of the chitosan micron hydrogel to 200% of the mass of chitosan %, and then inject the plasticized chitosan micron hydrogel containing notoginseng and nano-silver into the mold, and dry at 80°C under vacuum to obtain chitosan containing notoginseng and nano-silver sugar film. This chitosan film has the function of antibacterial and hemostatic.
上述实施例只为让熟悉此项技术的人士能够了解本发明的内容并据以实施,并不能以此限制本发明的保护范围。凡根据本发明精神实质所作的等效变化或修饰,都应涵盖在本发明的保护范围之内。 The above-mentioned embodiments are only for those skilled in the art to understand the content of the present invention and implement it accordingly, and shall not limit the protection scope of the present invention. All equivalent changes or modifications made according to the spirit of the present invention shall fall within the protection scope of the present invention.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210063025 CN102604138B (en) | 2012-03-12 | 2012-03-12 | Method for preparing chitosan substrate film by self-deposition of micron gel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210063025 CN102604138B (en) | 2012-03-12 | 2012-03-12 | Method for preparing chitosan substrate film by self-deposition of micron gel |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102604138A CN102604138A (en) | 2012-07-25 |
CN102604138B true CN102604138B (en) | 2013-09-11 |
Family
ID=46521946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210063025 Expired - Fee Related CN102604138B (en) | 2012-03-12 | 2012-03-12 | Method for preparing chitosan substrate film by self-deposition of micron gel |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102604138B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104707238B (en) * | 2015-03-11 | 2017-11-07 | 浙江大学 | The subcutaneous embedded analgesia pump of Epidural cavity with anti-infective function |
CN104910404B (en) * | 2015-06-24 | 2018-04-27 | 武汉工程大学 | A kind of chitosan-glycerine-nano silver sponge and its preparation method and application |
CN106049057A (en) * | 2016-05-31 | 2016-10-26 | 东华大学 | Preparation method of hydrophilic and antistatic polyester fiber |
CN108066813A (en) * | 2016-11-18 | 2018-05-25 | 南京理工大学 | A kind of preparation method for carrying medicine chitosan film |
CN107050524A (en) * | 2016-12-23 | 2017-08-18 | 江南大学 | A kind of preparation method of novel antibacterial composite biological material |
CN110079884B (en) * | 2019-05-08 | 2021-11-02 | 东华大学 | A kind of preparation method of high specific surface area polyimide precipitation fiber |
CN111467576B (en) * | 2020-04-29 | 2023-04-18 | 上海市东方医院(同济大学附属东方医院) | Artificial gallbladder wall synthetic material, preparation method and application thereof, and artificial gallbladder wall |
CN111944366B (en) * | 2020-07-08 | 2022-02-08 | 中山大学 | Preparation method and application of high-adhesion hydrogel coating |
CN113440643B (en) * | 2021-06-10 | 2022-04-29 | 武汉大学 | Surface antibacterial treatment method of absorbable surgical material |
CN113425889B (en) * | 2021-06-25 | 2023-01-24 | 延安大学 | A kind of antibacterial hemostatic sponge and its preparation method and application |
CN114685823B (en) * | 2021-12-13 | 2024-02-09 | 河南健康广济生物技术有限公司 | Anti-curling chitosan hydrogel film, preparation method thereof and chronic wound dressing |
CN115010981B (en) * | 2022-06-24 | 2023-12-05 | 遵义医科大学附属口腔医院 | Solid product containing amino indissolvable polymer, preparation method and application thereof |
CN115252879A (en) * | 2022-07-13 | 2022-11-01 | 肖地生 | Preparation method and application of chitosan hemostatic material |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1422668A (en) * | 2001-11-29 | 2003-06-11 | 浙江大学 | Medical micro porouse chitoglycan asymmetric film and preparation method thereof |
CN101225192A (en) * | 2008-02-02 | 2008-07-23 | 厦门大学 | A kind of preparation method of chitosan reinforced rod |
-
2012
- 2012-03-12 CN CN 201210063025 patent/CN102604138B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1422668A (en) * | 2001-11-29 | 2003-06-11 | 浙江大学 | Medical micro porouse chitoglycan asymmetric film and preparation method thereof |
CN101225192A (en) * | 2008-02-02 | 2008-07-23 | 厦门大学 | A kind of preparation method of chitosan reinforced rod |
Non-Patent Citations (4)
Title |
---|
王征科等."梯度渗透法组装仿木年轮结构壳聚糖棒材".《浙江大学学报(工学版)》.2006,第40卷(第11期),第1870页实验部分. |
王征科等."梯度渗透法组装仿木年轮结构壳聚糖棒材".《浙江大学学报(工学版)》.2006,第40卷(第11期),第1870页实验部分. * |
胡巧玲等."原位沉析法制备壳聚糖棒材的研究".《高等学校化学学报》.2003,第24卷(第3期),第528~529页的实验部分. |
胡巧玲等."原位沉析法制备碳酸钙/壳聚糖三维复合材料的研究".《高等学校化学学报》.2006,第27卷(第3期),第575~576页的实验部分. |
Also Published As
Publication number | Publication date |
---|---|
CN102604138A (en) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102604138B (en) | Method for preparing chitosan substrate film by self-deposition of micron gel | |
Wei et al. | Polysaccharides-modified chitosan as improved and rapid hemostasis foam sponges | |
Zhang et al. | Application status and technical analysis of chitosan-based medical dressings: A review | |
CN103446621B (en) | Preparation method of nano-silver-containing sodium alginate based antibacterial medical dressing | |
CN102961777B (en) | Method for preparing porous compound type high permeability absorption hemostasis coating with modified nano-crystalline cellulose | |
CN105903064B (en) | A kind of chitosan microball and its preparation method and application | |
CN102028966B (en) | Manufacturing method of chitosan hemostatic membrane with high water-absorbing swelling performance | |
CN109646710B (en) | A hemostatic material for clinical hemostasis and preparation method thereof | |
CN110507844A (en) | An absorbable composite material for local acute hemostasis based on oxidized bacterial cellulose and its preparation method | |
CN102973984B (en) | Preparation method and application of composite porous scaffold | |
CN107118361B (en) | Silk fibroin/carboxymethyl chitosan composite gel and preparation method thereof | |
CN107130333B (en) | A kind of alginic acid and chitosan blended fiber and preparation method thereof | |
CN107501579B (en) | Chitosan hemostatic material formed by covalent crosslinking and preparation method thereof | |
CN107915848A (en) | A kind of preparation method of chitin whisker/hydroxyl butyl chitosan temperature-sensitive hydrogel | |
CN106620832A (en) | Transparent antibacterial hydrogel dressing as well as preparation method and application thereof | |
CN110141677A (en) | Absorbable material for local acute hemostasis and preparation method thereof | |
CN107158454A (en) | The preparation method of the porous hemostatic microsphere of chitin | |
WO2021027006A1 (en) | Novel degradable hemostatic material and preparation method therefor | |
CN118001450A (en) | Chitosan/quaternized chitosan sponge and preparation method and application thereof | |
Xu et al. | Etamsylate loaded oxidized Konjac glucomannan-ε-polylysine injectable hydrogels for rapid hemostasis and wound healing | |
CN103012859B (en) | Chitosan and propylene glycol alginate blending material as well as preparation method and application thereof | |
CN106822987B (en) | A kind of preparation method of the porous ball hemostatic material of chitin-alginic acid salt | |
CN103191441B (en) | Method for preparing stimuli-response type esterified nano cellulose prodrug sustained-release material | |
CN102886066B (en) | Preparation method of calcium-containing soluble hemostatic material | |
CN103933601B (en) | A kind of shitosan compound hemostatic powder and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130911 Termination date: 20160312 |
|
CF01 | Termination of patent right due to non-payment of annual fee |